"Blood-based biomarkers have changed the diagnosis of Alzheimer’s disease faster than almost any test for older adults," says Richard Stefanacci, DO.

A sample of your blood can reveal much about your health. But it can be hard to know which blood tests are truly worth taking ...

Houston clinics now offer a blood test that looks for signals of more than 50 cancers, but doctors say it does not replace routine screenings.

The 6-minute walk test is an effective screening tool for identifying impaired cardiorespiratory fitness in patients with psoriatic arthritis.

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...

A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...

The FDA has cleared the new single-biomarker pTau217 blood test to help doctors detect signs of Alzheimer's. Medical News Today speaks to 4 experts to learn more about how it's different from other ...

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced ...

The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. Sign up here.